{
  "name": "Paroxetine",
  "genericName": "paroxetine",
  "brandNames": ["Paxil", "Paxil CR"],
  "tags": ["SSRI", "Antidepressant"],
  "dosing": {
    "adult_acute": "20 mg once daily, may increase weekly",
    "adult_maintenance": "20-50 mg/day (MDD), 40-60 mg/day (OCD, Panic, Social Anxiety)",
    "notes": "Take in morning; CR formulation allows once-daily dosing; most anticholinergic SSRI",
    "canadian_clinical": {
      "starting_dose": "10-20 mg once daily in the morning",
      "titration_schedule": "Increase by 10 mg weekly based on response and tolerability",
      "max_dose_evidence": "50 mg/day (MDD), 60 mg/day (OCD/Panic)",
      "max_dose_practice": "60 mg/day; rarely exceed due to side effects",
      "inpatient_strategy": "Start 20 mg; can increase to 40 mg within 2 weeks",
      "outpatient_strategy": "Start 10-20 mg; titrate slowly; higher discontinuation syndrome risk - taper carefully"
    }
  },
  "warnings": [
    "Black box warning: Increased suicidal thinking in children/adolescents/young adults",
    "HIGHEST risk of discontinuation syndrome among SSRIs - requires slow taper",
    "Strong CYP2D6 inhibitor - multiple drug interactions",
    "Most anticholinergic SSRI - dry mouth, constipation, urinary retention",
    "Weight gain more common than other SSRIs",
    "Pregnancy Category D - avoid in pregnancy (cardiac malformations)"
  ],
  "cautions": {
    "renal": "CrCl <30: Start 10 mg, max 40 mg/day",
    "hepatic": "Start 10 mg/day in severe hepatic impairment",
    "pregnancy": "Category D - avoid; associated with cardiac malformations; consider switching before conception"
  },
  "citations": ["APA Practice Guidelines for MDD", "CANMAT 2016", "Paxil FDA Label"]
}
